You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

List of Excipients in API triamcinolone acetonide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing triamcinolone acetonide

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
ER Squibb & Sons LLC KENALOG-40 triamcinolone acetonide 0003-0293 BENZYL ALCOHOL
ER Squibb & Sons LLC KENALOG-40 triamcinolone acetonide 0003-0293 CARBOXYMETHYLCELLULOSE SODIUM
ER Squibb & Sons LLC KENALOG-40 triamcinolone acetonide 0003-0293 HYDROCHLORIC ACID
ER Squibb & Sons LLC KENALOG-40 triamcinolone acetonide 0003-0293 NITROGEN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing triamcinolone acetonide

Company Ingredient NDC Excipient
L Perrigo Company triamcinolone acetonide 0113-0443 ANHYDROUS DEXTROSE
L Perrigo Company triamcinolone acetonide 0113-0443 BENZALKONIUM CHLORIDE
L Perrigo Company triamcinolone acetonide 0113-0443 CARBOXYMETHYLCELLULOSE SODIUM
L Perrigo Company triamcinolone acetonide 0113-0443 CELLULOSE, MICROCRYSTALLINE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for triamcinolone acetonide

Excipient focus: ALCOHOL

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DEXTROSE

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: BENZYL ALCOHOL

Excipient focus: CALCIUM CHLORIDE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

triamcinolone acetonide drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM

Company Ingredient NDC
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0003
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0005
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0336
Crown Laboratories triamcinolone acetonide 0316-0175
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CERESIN

Excipient focus: CETYL ALCOHOL

Excipient focus: CETYL ESTERS WAX

Excipient focus: CETYL PALMITATE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: DEXTROSE

Excipient focus: DEXTROSE MONOHYDRATE

Excipient focus: DIMETHICONE

Excipient focus: DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE DISODIUM ANHYDROUS

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: HIGH DENSITY POLYETHYLENE

Excipient focus: HYDROCHLORIC ACID

triamcinolone acetonide drug variants not containing HYDROCHLORIC ACID

Company Ingredient NDC
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0003
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0005
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0336
Crown Laboratories triamcinolone acetonide 0316-0175
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: ISOBUTANE

Excipient focus: ISOPROPYL PALMITATE

Excipient focus: LACTIC ACID

Excipient focus: LANOLIN ALCOHOLS

Excipient focus: LIGHT MINERAL OIL

Excipient focus: MAGNESIUM CHLORIDE

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE WAX

Excipient focus: MINERAL OIL

Excipient focus: NITROGEN

Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION

Excipient focus: PARAFFINUM LIQUIDUM

Excipient focus: PECTIN

Excipient focus: PECTIN, CITRUS

Excipient focus: PETROLATUM

Excipient focus: POLAWAX POLYSORBATE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYOXYL 40 STEARATE

Excipient focus: POLYSORBATE 20

Excipient focus: POLYSORBATE 40

Excipient focus: POLYSORBATE 60

Excipient focus: POLYSORBATE 80

triamcinolone acetonide drug variants not containing POLYSORBATE 80

Company Ingredient NDC
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0003
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0005
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0336
Crown Laboratories triamcinolone acetonide 0316-0175
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POTASSIUM CHLORIDE

Excipient focus: POTASSIUM SORBATE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLENE GLYCOL MONOSTEARATE

Excipient focus: PROPYLENE GLYCOL STEARATE

Excipient focus: PROPYLPARABEN

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

triamcinolone acetonide drug variants not containing SODIUM HYDROXIDE

Company Ingredient NDC
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0003
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0005
E Fougera & Co a division of Fougera Pharmaceuticals Inc triamcinolone acetonide 0168-0336
Crown Laboratories triamcinolone acetonide 0316-0175
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SORBIC ACID

Excipient focus: SORBITAN MONOPALMITATE

Excipient focus: SORBITAN MONOSTEARATE

Excipient focus: SORBITAN SESQUIOLEATE

Excipient focus: SORBITOL

Excipient focus: STEARYL ALCOHOL

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: WHITE PETROLATUM

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links